+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
Schizophrenia Global Market Report 2024 - Product Thumbnail Image

Schizophrenia Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Kidney Disease Global Market Report 2024 - Product Thumbnail Image

Kidney Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Diabetic Kidney Disease Global Market Report 2024 - Product Thumbnail Image

Diabetic Kidney Disease Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Crohn`s Disease (CD) Therapy - Global Strategic Business Report - Product Thumbnail Image

Crohn`s Disease (CD) Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 142 Pages
  • Global
From
Thyroid Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Thyroid Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 344 Pages
  • Global
From
Pediatric Vaccine Global Market Report 2024 - Product Thumbnail Image

Pediatric Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Ocular Hypertension Treatment Global Market Report 2024 - Product Thumbnail Image

Ocular Hypertension Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Crohn's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Spinal Cord Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Multiple Sclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Multiple Sclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Loading Indicator